131 Haney EM, Huffman LH, Bougatsos C, et al Screening and treatment for lipid disorders in children and adolescents: systematic evidence review for the US Preventive Services Task Force Pediatrics 2007;120(1):e189–e214 132 Juonala M, Viikari JS, Ronnemaa T, et al Associations of dyslipidemias from childhood to adulthood with carotid intima-media thickness, elasticity, and brachial flow-mediated dilatation in adulthood: the Cardiovascular Risk in Young Finns Study Arterioscler Thromb Vasc Biol 2008;28(5):1012–1017 133 Mahoney LT, Burns TL, Stanford W, et al Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: the Muscatine Study J Am Coll Cardiol 1996;27(2):277–284 134 Li S, Chen W, Srinivasan SR, et al Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study JAMA 2003;290(17):2271–2276 135 Frontini MG, Srinivasan SR, Xu J, et al Usefulness of childhood non-high density lipoprotein cholesterol levels versus other lipoprotein measures in predicting adult subclinical atherosclerosis: the Bogalusa Heart Study Pediatrics 2008;121(5):924–929 136 Kieltyka L, Urbina EM, Tang R, et al Framingham risk score is related to carotid artery intima-media thickness in both white and black young adults: the Bogalusa Heart Study Atherosclerosis 2003;170(1):125–130 137 Magnussen CG, Raitakari OT, Thomson R, et al Utility of currently recommended pediatric dyslipidemia classifications in predicting dyslipidemia in adulthood: evidence from the Childhood Determinants of Adult Health (CDAH) study, Cardiovascular Risk in Young Finns Study, and Bogalusa Heart Study Circulation 2008;117(1):32–42 138 Stuhldreher WL, Orchard TJ, Donahue RP, et al Cholesterol screening in childhood: sixteen-year Beaver County Lipid Study experience J Pediatr 1991;119(4):551–556 139 Jiang X, Srinivasan SR, Webber LS, Wattigney WA, Berenson GS Association of fasting insulin level with serum lipid and lipoprotein levels in children, adolescents, and young adults: the Bogalusa Heart Study Arch Intern Med 1995;155(2):190–196 140 Kwiterovich PO Jr Recognition and management of dyslipidemia in children and adolescents J Clin Endocrinol Metab 2008;93(11):4200–4209 141 Gidding SS, Champagne MA, de Ferranti SD, et al The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association Circulation 2015;132(22):2167–2192 142 Wald DS, Bestwick JP, Morris JK, et al Childparent familial hypercholesterolemia screening in primary care N Engl J Med 2016;375(17):1628–1637 143 de Ferranti SD, Rodday AM, Mendelson MM, et al Prevalence of familial hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES) Circulation 2016;133(11):1067– 1072 144 Stone NJ, Levy RI, Fredrickson DS, Verter J Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia Circulation 1974;49(3):476–488 145 Nordestgaard BG, Chapman MJ, Humphries SE, et al Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society Eur Heart J 2013;34(45):3478–3490a ...Study Pediatrics 2008;121(5):924–929 136 Kieltyka L, Urbina EM, Tang R, et al Framingham risk score is related to carotid... 2003;170(1):125–130 137 Magnussen CG, Raitakari OT, Thomson R, et al Utility of currently recommended pediatric dyslipidemia classifications in predicting dyslipidemia in adulthood: evidence from the